Home » Authors » Peter O'Donnell

Peter O'Donnell

Articles

ARTICLES

EU Says The Value Of Its Research Programs 'Hazy'

Jan. 2, 2008

By Peter O'Donnell

EU Says The Value Of Its Research Programs 'Hazy'

Jan. 2, 2008

By Peter O'Donnell

EU Moving to Tighten Rules On Flow Of Drug Information

Dec. 26, 2007

By Peter O'Donnell

EU Moving to Tighten Rules On Flow Of Drug Information

Dec. 26, 2007

By Peter O'Donnell

One Step Forward for Small European Firms In Biotech

Dec. 19, 2007

By Peter O'Donnell

One Step Forward for Small European Firms In Biotech

Dec. 19, 2007

By Peter O'Donnell

Lithuania Under Fire For Biogeneric Drug

Dec. 12, 2007

By Peter O'Donnell

Lithuania Under Fire For Biogeneric Drug

Dec. 12, 2007

By Peter O'Donnell

European Generic Firms Mount Biosimilars Push

Dec. 5, 2007

By Peter O'Donnell

European Biotech Industry Goes On GMO Offensive

Dec. 5, 2007

By Peter O'Donnell

View All Articles by Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...